What is the recommended cervical cancer screening interval for women aged 30-65?

The recommended cervical cancer screening interval for women aged 30-65 is every 5 years with HPV cotesting. This interval is supported by guidelines from health organizations such as the American College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task Force (USPSTF).

This approach combines both a Pap smear and HPV (human papillomavirus) testing in a single screening. The presence of HPV is significant, as it is the primary cause of cervical cancer, and testing for it alongside the Pap smear allows for a more comprehensive assessment of cervical health. The 5-year interval is based on evidence that demonstrates this frequency is effective in detecting precancerous changes or cervical cancer in this age group while also minimizing unnecessary procedures and anxiety associated with more frequent screening.

The alternatives offered do not reflect the current recommendations or evidence-based practices for cervical cancer screening. For instance, annual screenings can lead to overtreatment and increased healthcare costs without providing added benefits in terms of cancer detection. Screening every 3 years without HPV testing may not adequately account for the risk factors associated with HPV. Lastly, a 10-year interval wouldn't be appropriate, as it could allow for undetected changes that might develop into cancer over a longer